Concentration of ciprofloxacin in human serum, lung and pleural tissues and fluids during and after lung surgery.

Suppr

超能文献

作者信息

Hopf G, Böcker R, Estler C J, Radtke H J, Floh W

机构信息

Institut für Pharmakologie und Toxikologie, Universität Erlangen-Nürnberg.

出版信息

Infection. 1988;16(1):29-30. doi: 10.1007/BF01646928.

DOI:10.1007/BF01646928

PMID:3360495

Abstract

摘要

相似文献

Concentration of ciprofloxacin in human serum, lung and pleural tissues and fluids during and after lung surgery.

Infection. 1988;16(1):29-30. doi: 10.1007/BF01646928.

Penetration of ciprofloxacin into human pleural fluid.环丙沙星在人胸腔积液中的渗透情况。

Antimicrob Agents Chemother. 1990 May;34(5):934-6. doi: 10.1128/AAC.34.5.934.

The penetration of ciprofloxacin into bronchial mucosa, lung parenchyma, and pleural tissue after intravenous administration.

Eur J Clin Pharmacol. 1993;44(1):101-2. doi: 10.1007/BF00315290.

Penetration of ciprofloxacin and metabolites into human lung, bronchial and pleural tissue after 250 and 500 mg oral ciprofloxacin.口服250毫克和500毫克环丙沙星后，环丙沙星及其代谢产物在人肺、支气管和胸膜组织中的渗透情况。

Chemotherapy. 1991;37(4):229-38. doi: 10.1159/000238860.

[Kinin system components, free kinins and proteinase inhibitors in the edematous fluids of nephrotic syndrome patients].[肾病综合征患者水肿液中的激肽系统成分、游离激肽和蛋白酶抑制剂]

Vopr Med Khim. 1979 Sep-Oct;25(5):588-99.

Clara cell protein (CC16) in pleural fluids: a marker of leakage through the visceral pleura.胸腔积液中的克拉拉细胞蛋白（CC16）：通过脏层胸膜渗漏的标志物。

Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):962-9. doi: 10.1164/ajrccm.157.3.9707138.

Ciprofloxacin concentrations in lung tissue following a single 400 mg intravenous dose.

J Antimicrob Chemother. 1999 Mar;43 Suppl A:43-8. doi: 10.1093/jac/43.suppl_1.43.

The distribution of ciprofloxacin and its metabolites in human plasma, pulmonary and bronchial tissues.

Int J Clin Pharmacol Ther Toxicol. 1991 Sep;29(9):352-6.

State of the art. The pleura.前沿技术。胸膜。

Am Rev Respir Dis. 1988 Jul;138(1):184-234. doi: 10.1164/ajrccm/138.1.184.

The immunoelectrophoretic patterns of some body fluids of sheep.绵羊某些体液的免疫电泳图谱。

Res Vet Sci. 1968 Jul;9(4):324-30.

引用本文的文献

Ciprofloxacin is actively transported across bronchial lung epithelial cells using a Calu-3 air interface cell model.环丙沙星通过 Calu-3 气道上皮细胞模型被主动转运至支气管肺上皮细胞中。

Antimicrob Agents Chemother. 2013 Jun;57(6):2535-40. doi: 10.1128/AAC.00306-13. Epub 2013 Mar 18.

Ciprofloxacin penetration into the pulmonary parenchyma in Japanese patients.环丙沙星在日本患者肺实质中的渗透情况。

Surg Today. 2007;37(4):282-4. doi: 10.1007/s00595-006-3393-4. Epub 2007 Mar 26.

Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.新型氟喹诺酮类抗菌药物的比较药代动力学与药效学

Clin Pharmacokinet. 2001;40(3):169-87. doi: 10.2165/00003088-200140030-00003.

The penetration of ciprofloxacin into bronchial mucosa, lung parenchyma, and pleural tissue after intravenous administration.

Eur J Clin Pharmacol. 1993;44(1):101-2. doi: 10.1007/BF00315290.

Penetration of ciprofloxacin into bronchial secretions from mechanically ventilated patients with nosocomial bronchopneumonia.环丙沙星在机械通气的医院获得性支气管肺炎患者支气管分泌物中的渗透情况。

Antimicrob Agents Chemother. 1994 Apr;38(4):901-4. doi: 10.1128/AAC.38.4.901.

Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。

Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.

Penetration of ciprofloxacin into human pleural fluid.环丙沙星在人胸腔积液中的渗透情况。

Antimicrob Agents Chemother. 1990 May;34(5):934-6. doi: 10.1128/AAC.34.5.934.

Clinical pharmacokinetics of ciprofloxacin.

Clin Pharmacokinet. 1990 Dec;19(6):434-61. doi: 10.2165/00003088-199019060-00003.

Possible interaction of fluoroquinolones with the benzodiazepine-GABAA-receptor complex.氟喹诺酮类药物与苯二氮䓬-GABAA受体复合物之间可能的相互作用。

Br J Clin Pharmacol. 1990 Jul;30(1):63-70. doi: 10.1111/j.1365-2125.1990.tb03744.x.

Occurrence of quinolone resistance in Staphylococcus aureus from nosocomial infection.医院感染金黄色葡萄球菌中喹诺酮耐药性的发生情况。

Epidemiol Infect. 1992 Dec;109(3):413-21. doi: 10.1017/s0950268800050408.

本文引用的文献

The in vitro and in vivo activity of ciprofloxacin.环丙沙星的体外和体内活性。

Eur J Clin Microbiol. 1984 Aug;3(4):339-43. doi: 10.1007/BF01977490.

Penetration of ciprofloxacin into human lung tissue following intravenous injection.静脉注射后环丙沙星在人肺组织中的渗透情况。

Infection. 1986 Nov-Dec;14(6):299-300. doi: 10.1007/BF01643967.

Dose ranging study and constant infusion evaluation of ciprofloxacin.环丙沙星的剂量范围研究和持续输注评估。

Antimicrob Agents Chemother. 1986 Sep;30(3):440-3. doi: 10.1128/AAC.30.3.440.

Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay.环丙沙星代谢产物的抗菌活性及其在生物测定中的意义。

Arzneimittelforschung. 1987 Feb;37(2):131-4.

[Biotransformation of selected gyrase inhibitors].[选定的回旋酶抑制剂的生物转化]

Infection. 1986;14 Suppl 1:S54-9. doi: 10.1007/BF01645200.

Determination of ciprofloxacin in biological samples by reversed-phase high performance liquid chromatography.采用反相高效液相色谱法测定生物样品中的环丙沙星。

Ther Drug Monit. 1986;8(3):340-5. doi: 10.1097/00007691-198609000-00018.

Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration.口服和静脉注射后环丙沙星在健康志愿者体内的药代动力学。

Eur J Clin Microbiol. 1986 Apr;5(2):179-86. doi: 10.1007/BF02013983.

[A cross-over study on the effectiveness of ofloxacin and ciprofloxacin administered orally].

Infection. 1986;14 Suppl 1:S82-6. doi: 10.1007/BF01645207.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验